Alx Oncology Holdings ALXO Insider Ownership

NASDAQ ALXO
$2.01 -0.02 (-0.99%)
As of: Sep 4, 2026 · 11:49 AM EDT

Insider Holdings by Owner

3.78Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
23.59%
+0.0014% pp QoQ
Shares Held by Insiders
12.64Mn
filed for Sep 2026
+0.01% QoQ
Shares Outstanding
53.58Mn
53,577,066 shares
Direct Holdings
1.52Mn
Indirect: 11.12Mn
Net Shares Traded (QoQ)
+770
net buying in Sep 2026
Insiders Holding Shares
7
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

ALXO's three largest insider shareholders as of August 29, 2026 are Corey S Goodman (Director, 8.45Mn shares), Associates, Llc Lsv (TenPercentOwner, 2.38Mn shares), Associates, Llc Lsv (TenPercentOwner, 2.38Mn shares).

Form 4 Holdings

Insiders Holding ALXO

Insiders 7
Shares held 3.78Mn
Of outstanding 7.05%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Associates, Llc Lsv TenPercentOwner 0 2,383,282 2,383,282 63.1% 15 Dec, 2021
2 Jaume Pons President Cso 579,388 0 579,388 15.3% 21 Feb, 2025
3 Sophia Randolph Chief Medical Officer 325,711 0 325,711 8.6% 16 Aug, 2024
4 Jason Lettmann Chief Executive Officer 294,379 0 294,379 7.8% 18 Aug, 2026
5 Shelly Wong Svp, Finance And Cao 87,828 0 87,828 2.3% 18 Aug, 2026
6 Harish Shantharam Chief Financial Officer 75,000 0 75,000 2.0% 20 Aug, 2025
7 Rekha Hemrajani Director 33,000 0 33,000 0.9% 04 Dec, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,145 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
17 Aug, 2026 Jason Lettmann Chief Executive Officer Disposed S 2,230 $1.93 $4.30K 294,379 Direct
17 Aug, 2026 Shelly Wong Svp, Finance And Cao Disposed S 573 $1.93 $1.11K 87,828 Direct
01 Jul, 2026 Shelly Wong Svp, Finance And Cao Disposed S 1,404 $2.04 $2.86K 88,401 Direct
16 Apr, 2026 Jeff E. Knight Chief Dev Operating Officer Acquired A 800,000 $0.00 $0 800,000 Direct
16 Apr, 2026 Jeff E. Knight Chief Dev Operating Officer Acquired A 800,000 $0.00 $0 800,000 Direct
16 Apr, 2026 Barbara Klencke Chief Medical Officer Acquired A 100,000 $0.00 $0 100,000 Direct
16 Apr, 2026 Jeff E. Knight Chief Dev Operating Officer Acquired A 800,000 $0.00 $0 800,000 Direct
16 Apr, 2026 Jeff E. Knight Chief Dev Operating Officer Acquired A 800,000 $0.00 $0 800,000 Direct
19 Mar, 2026 Jason Lettmann Chief Executive Officer Disposed S 12,311 $2.17 $26.71K 293,609 Direct
19 Mar, 2026 Shelly Pinto Svp, Finance And Cao Disposed S 903 $2.17 $1.96K 86,805 Direct
03 Mar, 2026 Barbara Klencke Chief Medical Officer Acquired A 700,000 $0.00 $0 700,000 Direct
18 Feb, 2026 Shelly Pinto Svp, Finance And Cao Disposed S 565 $2.27 $1.28K 87,708 Direct
17 Feb, 2026 Jason Lettmann Chief Executive Officer Disposed F 2,201 $2.27 $5.00K 305,920 Direct
26 Jan, 2026 Harish Shantharam Chief Financial Officer Acquired A 303,000 $0.00 $0 303,000 Direct
26 Jan, 2026 Harish Shantharam Chief Financial Officer Acquired A 303,000 $0.00 $0 303,000 Direct
26 Jan, 2026 Shelly Pinto Svp, Finance And Cao Acquired A 192,000 $0.00 $0 192,000 Direct
26 Jan, 2026 Harish Shantharam Chief Financial Officer Acquired A 303,000 $0.00 $0 303,000 Direct
26 Jan, 2026 Harish Shantharam Chief Financial Officer Acquired A 303,000 $0.00 $0 303,000 Direct
26 Jan, 2026 Harish Shantharam Chief Financial Officer Acquired A 303,000 $0.00 $0 303,000 Direct
26 Jan, 2026 Jason Lettmann Chief Executive Officer Acquired A 912,000 $0.00 $0 912,000 Direct